Skip to main content
logo
CTCBIO Inc. (KOSDAQ:060590)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,110.00
+50.00 (1.63%)
At close: Sep 4, 2026

CTCBIO Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
131,539123,769119,877137,878165,206140,318
Revenue Growth
17.21%3.25%-13.06%-16.54%17.74%7.91%
Gross Profit
52,75849,95949,23242,57054,05633,090
Operating Income
11,3496,250-5,014-4,57811,230-2,938
Net Income
7,5133,241-5,220-15,5884,704-7,318
Earnings Per Share
313.12135.54-218.00-652.00197.00-329.29
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
22,82717,71119,17124,67924,3517,695
Total Debt
40,33338,74332,87035,28939,95840,656
Net Cash (Debt)
-17,506-21,032-13,698-10,610-15,607-32,961
Net Cash Growth
------
Net Cash Per Share
-729.59-879.69-572.03-443.76-655.27-1483.12

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
8,7364,3834,4968,21618,2246,457
Capital Expenditures
-1,549-786.53-2,139-1,885-3,173-1,674
Free Cash Flow
7,1873,5972,3576,33115,0514,783
Free Cash Flow Growth
-5.69%52.60%-62.77%-57.94%214.66%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
40.11%40.37%41.07%30.88%32.72%23.58%
Operating Margin
8.63%5.05%-4.18%-3.32%6.80%-2.09%
Pretax Margin
6.64%2.41%-4.43%-11.40%0.12%-5.48%
Profit Margin
5.71%2.62%-4.35%-11.31%2.85%-5.21%
FCF Margin
5.46%2.91%1.97%4.59%9.11%3.41%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
9.8434.12--32.02-
P/FCF Ratio
10.3530.7566.4440.4110.0144.23
PS Ratio
0.570.891.311.860.911.51